Search Results
Search results for "positive allosteric modulators"
Results found for "positive allosteric modulators"
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models
- Dr. Marta Filizola | Dr. GPCR Ecosystem
computational structural biology tools and rational drug design approaches, ranging from molecular modeling
- Developing new tools to uncover GPCR signaling patterns with Remi Janicot | Dr. GPCR Ecosystem
Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
His laboratory uses knock-out and transgenic mouse models, along with different cell culture systems,
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
different signals on a molecular level and how these are translated into physiological functions in various model
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
The result was a structured group management model built around four specialized subgroups, each with 15 - subgroups, leadership training, and delegation 40:41 What excites Gloriam today - open science models
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
interested in translational innovation Biotech investors and strategic leaders seeking new drug development models
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model
- Dr. GPCR Team | Dr. GPCR Ecosystem
Currently serving as a Post Doctoral research fellow at Monash University, John plays a pivotal role elucidating the molecular basis of membrane protein signalling using quantitative assays and molecular modelling
- GPCR Masterclass Live Courses | Dr. GPCR Ecosystem
Pierce | Midewestern University Introduction to GLP-1 pharmacology Translational Pharmacology & Disease Models
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind a pre-built mental model for what to freeze, what to protect, and what to let continue.
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
Her lab uses homology modeling, machine learning, and collaborative sensory experiments to predict bitterness safety, and pharmacokinetics - but bitterness prediction was rarely incorporated until clinical or even post-market
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
📌 Measuring Bias: A Quantitative Approach 🔹 The operational model provides a structured way to measure
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
The system is modular and adaptable, opening doors for systems biology and context-specific interaction
















